Application
Western blot analysis of CRAT antibody (C-term) in MDA-MB231 cell line lysates (35ug/lane). CRAT (arrow) was detected using the purified Pab.Application
CRAT Antibody (C-term) IHC analysis in formalin fixed and paraffin embedded human Skeletal muscle followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the CRAT Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.Application
CRAT Antibody (C-term) flow cytometric analysis of CEM cells (bottom histogram) compared to a negative control cell (top histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | CRAT Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | CRAT; CAT1; Carnitine O-acetyltransferase; Carnitine acetyltransferase |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHCFC |
| WB:1:50~100 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | CAT1 |
|---|---|
| Alternative Names | CRAT CAT1 Carnitine O-acetyltransferase Carnitine acetyltransferase |
| Molecular Weight(MW) | 70858 Da |
| Function | Carnitine acetylase is specific for short chain fatty acids. Carnitine acetylase seems to affect the flux through the pyruvate dehydrogenase complex. It may be involved as well in the transport of acetyl-CoA into mitochondria |
| Tissue Specificity | Mostly in skeletal muscle, less in heart, liver and pancreas, only weakly detectable in brain, placenta, lung and kidney |
| Cellular Localization | Endoplasmic reticulum (Potential). Peroxisome (Potential). Mitochondrion inner membrane; Peripheral membrane protein; Matrix side (Potential) Isoform 2: Peroxisome (Potential). |
| Entrez Gene | 1384 |
|---|
Application
Western blot analysis of CRAT antibody (C-term) in MDA-MB231 cell line lysates (35ug/lane). CRAT (arrow) was detected using the purified Pab.
Application
CRAT Antibody (C-term) IHC analysis in formalin fixed and paraffin embedded human Skeletal muscle followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the CRAT Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.
Application
CRAT Antibody (C-term) flow cytometric analysis of CEM cells (bottom histogram) compared to a negative control cell (top histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:50~100 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS. |
